Literature DB >> 22828870

Prevention of surgical site infections in bone and joint procedures.

Ralf-Peter Vonberg1, Petra Gastmeier.   

Abstract

There is strong evidence that preoperative nasal S. aureus screening/decolonization will significantly reduce surgical site infections (SSIs) after joint prostheses implantation. There is some evidence that antibiotic-containing bone cement may lower SSI rates. Timely administration of perioperative systemic antibiotic prophylaxis is recommended for patients with implants who are undergoing dental treatment, urogenital surgery, upper endoscopy, sigmoidoscopy, or colonoscopy. Advanced skin disinfection by chlorhexidine-gluconate-impregnated cloths may be protective. There is evidence that clippers are favored for hair removal, rather than razors, but no significant advantage, as compared with other modes of hair removal, has been found. Antibiotic-coated intramedullary nails and antibiotic-impregnated bone grafts may be useful for the treatment of chronic bone infections. No recommendation can be made for wound dressing types. Laminar air flow systems do not seem to prevent SSI but may even cause harm, instead. There is a strong association between the annual number of surgical procedures and low SSI rates.

Entities:  

Year:  2012        PMID: 22828870     DOI: 10.1007/s11908-012-0278-0

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  64 in total

Review 1.  Preoperative hair removal to reduce surgical site infection.

Authors:  Judith Tanner; Peter Norrie; Kate Melen
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 2.  Skin and soft-tissue infections: impact of resistant gram-positive bacteria.

Authors:  Mark A Wilson
Journal:  Am J Surg       Date:  2003-11-28       Impact factor: 2.565

Review 3.  [Perioperative antibiotic prophylaxis. Use in orthopaedics].

Authors:  M Széll; S Hofmann; M Pietsch; E Gerhart; C Wenisch
Journal:  Orthopade       Date:  2006-07       Impact factor: 1.087

4.  Clinical outcome and microbiological findings using antibiotic-loaded spacers in two-stage revision of prosthetic joint infections.

Authors:  Javier Cabo; Gorane Euba; Anna Saborido; María González-Panisello; María Angeles Domínguez; Jose L Agulló; Oscar Murillo; Ricard Verdaguer; Javier Ariza
Journal:  J Infect       Date:  2011-05-19       Impact factor: 6.072

5.  Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty.

Authors:  Aaron J Johnson; Jacqueline A Daley; Michael G Zywiel; Ronald E Delanois; Michael A Mont
Journal:  J Arthroplasty       Date:  2010-05-31       Impact factor: 4.757

6.  Antibiotics-impregnated cement spacers in the first step of two-stage revision for infected totally replaced hip joints: report of ten trial cases.

Authors:  Katsuyuki Dairaku; Michiaki Takagi; Hiroyuki Kawaji; Kan Sasaki; Masaji Ishii; Toshihiko Ogino
Journal:  J Orthop Sci       Date:  2009-12-08       Impact factor: 1.601

7.  Risk factors for prosthetic hip and knee infections according to arthroplasty site.

Authors:  T N Peel; M M Dowsey; J R Daffy; P A Stanley; P F M Choong; K L Buising
Journal:  J Hosp Infect       Date:  2011-08-06       Impact factor: 3.926

8.  The influence of procedure volumes and standardization of care on quality and efficiency in total joint replacement surgery.

Authors:  Kevin J Bozic; Judith Maselli; Penelope S Pekow; Peter K Lindenauer; Thomas P Vail; Andrew D Auerbach
Journal:  J Bone Joint Surg Am       Date:  2010-11-17       Impact factor: 5.284

9.  Guidelines for environmental infection control in health-care facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC).

Authors:  Lynne Sehulster; Raymond Y W Chinn
Journal:  MMWR Recomm Rep       Date:  2003-06-06

10.  Locally administered antibiotics for prophylaxis against surgical wound infection. An in vivo study.

Authors:  Seth R Yarboro; Elyse J Baum; Laurence E Dahners
Journal:  J Bone Joint Surg Am       Date:  2007-05       Impact factor: 5.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.